SOPH — Sophia Genetics SA Share News
0.000.00%
Last trade - 00:00- $620.58m
- $574.74m
- $77.27m
Brief: Sophia Genetics Announces Nomination Of Lila Tretikov To Board Of Directors
Sophia Genetics SA reports results for the quarter ended in March - Earnings Summary
Brief: Sophia Genetics Reports Fiscal Q1 2023 Financial Results
Sophia Genetics SA reports results for the quarter ended in December - Earnings Summary
Qiagen partners with Sophia Genetics on next-generation sequencing kits
Brief: SOPHiA Genetics Expands Partnership With Astrazeneca
Brief: Sophia Genetics Expands Partnership With Astrazeneca To Include Multimodal Approaches For Cancer Drug Development
Sophia Genetics SA reports results for the quarter ended in September - Earnings Summary
Brief: Sophia Genetics Reports Third Quarter Financial Results
Brief: Sophia Genetics SA Files For Mixed Shelf Of Up To $200 Mln
Sophia Genetics SA reports results for the quarter ended in June - Earnings Summary
Brief: Sophia Genetics Reports Financial Results For The Second Quarter Of Fiscal 2022
Brief: Sophia Genetics Reports Financial Results For The First Quarter Of Fiscal 2022
Brief: Sophia Genetics Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Institut Paoli Calmettes Extends Partnership With Sophia Genetics
Brief: Sophia Genetics SA- Announces Launch Of Deep-Lung-Iv Multimodal Clinical Study
Brief: Sophia Genetics Reports Third Quarter 2021 Financial Results And Raises 2021 Guidance
Sophia Genetics SA reports results for the quarter ended in June - Earnings Summary
Brief: Sophia Genetics Reports Second Quarter 2021 Financial Results And Issues 2021 Guidance